Beyond Blood Sugar: SGLT2 Inhibitors and Their Cardiorenal Protective Effects in Diabetes Management
For individuals with Type 1 Diabetes and advanced Type 2 Diabetes, the foundation of treatment remains insulin, but the quality of life is being dramatically improved by new insulin analogues and novel delivery methods. The goal is to more closely mimic the body's natural physiological insulin response. Ultra-long-acting insulin analogues, such as insulin icodec, are being developed to allow...
0 Commentarii 0 Distribuiri 30 Views 0 previzualizare